Antibody-mediated inhibition of ricin toxin retrograde transport

mBio

Volumn 5, Issue 2, 2014, Pages

  Yermakova, Anastasiya ^a,b   Klokk, Tove Irene ^c   Cole, Richard ^a,b   Sandvig, Kirsten ^c,d   Mantis, Nicholas J ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GLYCOLIPID; GLYCOPROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 24B11; NEUTRALIZING ANTIBODY; RAB7 PROTEIN; RICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CELL TRANSPORT; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; ENDOCYTOSIS; HOST CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SULFATION; TOXIN ANTIBODY COMPLEX; TRANS GOLGI NETWORK;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTITOXINS; CELL LINE; ENDOCYTOSIS; HUMANS; LYSOSOMES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROTEIN TRANSPORT; RICIN;

EID: 84899829096     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00995-13     Document Type: Article

References (48)

1. Johannes L, Römer W. 2010. Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 8:105-116. http://dx.doi.org/10.10 38/nrmicro2279.
2. O'Hara JM, Yermakova A, Mantis NJ. 2012. Immunity to ricin: fundamental insights into toxin-antibody interactions. Curr. Top. Microbiol. Immunol. 357:209-241. http://dx.doi.org/10.1007/82_2011_193.
3. Rutenber E, Ready M, Robertus JD. 1987. Structure and evolution of ricin B chain. Nature 326:624-626. http://dx.doi.org/10.1038/326624a0.
4. Sandvig K, Olsnes S, Pihl A. 1976. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. J. Biol. Chem. 251: 3977-3984.
5. Sandvig K, Skotland T, van Deurs B, Klokk TI. 2013. Retrograde transport of protein toxins through the Golgi apparatus. Histochem. Cell Biol. 140:317-326. http://dx.doi.org/10.1007/s00418-013-1111-z.
6. Johannes L, Popoff V. 2008. Tracing the retrograde route in protein trafficking. Cell 135:1175-1187. http://dx.doi.org/10.1016/j.cell.2008.12. 009.
7. van Deurs B, Sandvig K, Petersen OW, Olsnes S, Simons K, Griffiths G. 1988. Estimation of the amount of internalized ricin that reaches the trans-Golgi network. J. Cell Biol. 106:253-267. http://dx.doi.org/10.1083 /jcb.106.2.253.
8. Spooner RA, Watson PD, Marsden CJ, Smith DC, Moore KA, Cook JP, Lord JM, Roberts LM. 2004. Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem. J. 383: 285-293. http://dx.doi.org/10.1042/BJ20040742.
9. Jandhyala DM, Thorpe CM, Magun B. 2012. Ricin and Shiga toxins: effects on host cell signal transduction. Curr. Top. Microbiol. Immunol. 357:41-65. http://dx.doi.org/10.1007/82_2011_181.
10. Reisler RB, Smith LA. 2012. The need for continued development of ricin countermeasures. Adv. Prev. Med. 2012:149737. http://dx.doi.org/10.115 5/2012/149737.
11. Wolfe DN, Florence W, Bryant P. 2013. Current biodefense vaccine programs and challenges. Hum. Vaccin. Immunother. 9:1591-1597. http://dx.doi.org/10.4161/hv.24063.
12. Pasetti MF, Levine MM. 2012. Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clin. Vaccine Immunol. 19: 1707-1711. http://dx.doi.org/10.1128/CVI.00543-12.
13. Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H. 2004. Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clin. Microbiol. Rev. 17:926-941. http:// dx.doi.org/10.1128/CMR.17.4.926-941.2004.
14. Colombatti M, Johnson VG, Skopicki HA, Fendley B, Lewis MS, Youle RJ. 1987. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin. J. Immunol. 138:3339-3344.
15. McGuinness CR, Mantis NJ. 2006. Characterization of a novel highaffinity monoclonal immunoglobulin G antibody against the ricin B subunit. Infect. Immun. 74:3463-3470. http://dx.doi.org/10.1128/IAI.00324-06.
16. Prigent J, Panigai L, Lamourette P, Sauvaire D, Devilliers K, Plaisance M, Volland H, Créminon C, Simon S. 2011. Neutralising antibodies against ricin toxin. PLoS One 6:e20166. http://dx.doi.org/10.1371/journal. pone.0020166.
17. Vance DJ, Tremblay JM, Mantis NJ, Shoemaker CB. 2013. Stepwise engineering of heterodimeric single domain camelidVHHantibodies that passively protect mice from ricin toxin. J. Biol. Chem. 288:36538-36547. http://dx.doi.org/10.1074/jbc.M113.519207.
18. Yermakova A, Mantis NJ. 2011. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB). Vaccine 29:7925-7935. http://dx.doi.org/10.1016/j.vaccine.2011.08.075.
19. Yermakova A, Mantis NJ. 2013. Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments. Toxicon 72:29-34. http://dx.doi.org/10.1016/j.toxicon.2013.04.00 5.
20. Yermakova A, Vance DJ, Mantis NJ. 2012. Sub-domains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies. PLoS One 7:e44317. http://dx.doi.org/10.1371/journal.pone.0 044317.
21. Lemley PV, Amanatides P, Wright DC. 1994. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma 13:417-421. http://dx.doi.org/10.1089/hyb.1994. 13.417.
22. O'Hara JM, Neal LM, McCarthy EA, Kasten-Jolly JA, Brey RN, III, Mantis NJ. 2010. Folding domains within the ricin toxin A subunit as targets of protective antibodies. Vaccine 28:7035-7046. http://dx.doi.org/ 10.1016/j.vaccine.2010.08.020.
23. O'Hara JM, Mantis NJ. 2013. Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro. J. Immunol. Methods 395:71-78. http://dx.doi.org/10.1016/j.jim.2013.06.004.
24. Huotari J, Helenius A. 2011. Endosome maturation. EMBO J. 30: 3481-3500. http://dx.doi.org/10.1038/emboj.2011.286.
25. Rapak A, Falnes PO, Olsnes S. 1997. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc. Natl. Acad. Sci. U. S. A. 94:3783-3788. http://dx.doi.org/10.1 073/pnas.94.8.3783.
26. Slominska-Wojewodzka M, Gregers TF, Wälchli S, Sandvig K. 2006. EDEM is involved in retrotranslocation of ricin from the endoplasmic reticulum to the cytosol. Mol. Biol. Cell 17:1664-1675. http://dx.doi.org/ 10.1091/mbc.E05-10-0961.
27. McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC. 2013. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14:327-336. http:// dx.doi.org/10.1038/nrm3594.
28. Montfort W, Villafranca JE, Monzingo AF, Ernst SR, Katzin B, Rutenber E, Xuong NH, Hamlin R, Robertus JD. 1987. The three-dimensional structure of ricin at 2.8 A. J. Biol. Chem. 262:5398-5403.
29. Swimmer C, Lehar SM, McCafferty J, Chiswell DJ, Blättler WA, Guild BC. 1992. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants. Proc. Natl. Acad. Sci. U. S. A. 89:3756-3760. http://dx.doi.org/10.1073/pnas.89.9.3756.
30. Houston LL, Dooley TP. 1982. Binding of two molecules of 4-methylumbelliferyl galactose or 4-methylumbelliferyl N-acetylgalactosamine to the B chains of ricin and Ricinus communis agglutinin and to purified ricin B chain. J. Biol. Chem. 257:4147-4151.
31. Sphyris N, Lord JM, Wales R, Roberts LM. 1995. Mutational analysis of the Ricinus lectin B-chains. Galactose-binding ability of the 2 gamma subdomain of Ricinus communis agglutinin B-chain. J. Biol. Chem. 270: 20292-20297. http://dx.doi.org/10.1074/jbc.270.35.20292.
32. Yao J, Nellas RB, Glover MM, Shen T. 2011. Stability and sugar recognition ability of ricin-like carbohydrate binding domains. Biochemistry 50:4097-4104. http://dx.doi.org/10.1021/bi102021p.
33. Zentz C, Frénoy JP, Bourrillon R. 1978. Binding of galactose and lactose to ricin. Equilibrium studies. Biochim. Biophys. Acta 536:18-26. http:// dx.doi.org/10.1016/0005-2795(78)90047-8.
34. Kimura Y, Hase S, Kobayashi Y, Kyogoku Y, Ikenaka T, Funatsu G. 1988. Structures of sugar chains of ricin D. J. Biochem. 103:944-949.
35. Newton DL, Wales R, Richardson PT, Walbridge S, Saxena SK, Ackerman EJ, Roberts LM, Lord JM, Youle RJ. 1992. Cell surface and intracellular functions for ricin galactose binding. J. Biol. Chem. 267: 11917-11922.
36. Wales R, Richardson PT, Roberts LM, Woodland HR, Lord JM. 1991. Mutational analysis of the galactose binding ability of recombinant ricin B chain. J. Biol. Chem. 266:19172-19179.
37. Zhan J, de Sousa M, Chaddock JA, Roberts LM, Lord JM. 1997. Restoration of lectin activity to a non-glycosylated ricin B chain mutant by the introduction of a novel N-glycosylation site. FEBS Lett. 407:271-274. http://dx.doi.org/10.1016/S0014-5793(97)00341-4.
38. van Deurs B, Tønnessen TI, Petersen OW, Sandvig K, Olsnes S. 1986. Routing of internalized ricin and ricin conjugates to the Golgi complex. J. Cell Biol. 102:37-47. http://dx.doi.org/10.1083/jcb.102.1.37.
39. Tekle C, van Deurs B, Sandvig K, Iversen TG. 2008. Cellular trafficking of quantum dot-ligand bioconjugates and their induction of changes in normal routing of unconjugated ligands. Nano Lett. 8:1858-1865. http:// dx.doi.org/10.1021/nl0803848.
40. Huttner WB. 1988. Tyrosine sulfation and the secretory pathway. Annu. Rev. Physiol. 50:363-376. http://dx.doi.org/10.1146/annurev.ph.50.0301 88.002051.
41. Sandvig K, Torgersen ML, Engedal N, Skotland T, Iversen TG. 2010. Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine. FEBS Lett. 584:2626-2634. http://dx.doi.org/10.1 016/j.febslet.2010.04.008.
42. Stechmann B, Bai SK, Gobbo E, Lopez R, Merer G, Pinchard S, Panigai L, Tenza D, Raposo G, Beaumelle B, Sauvaire D, Gillet D, Johannes L, Barbier J. 2010. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141:231-242. http://dx.doi.org/10.1016/j.cell.2 010.01.043.
43. Noel R, Gupta N, Pons V, Goudet A, Garcia-Castillo MD, Michau A, Martinez J, Buisson DA, Johannes L, Gillet D, Barbier J, Cintrat JC. 2013. N-methyldihydroquinazolinone derivatives of retro-2 with enhanced efficacy against Shiga toxin. J. Med. Chem. 56:3404-3413. http:// dx.doi.org/10.1021/jm4002346.
44. Krautz-Peterson G, Chapman-Bonofiglio S, Boisvert K, Feng H, Herman IM, Tzipori S, Sheoran AS. 2008. Intracellular neutralization of Shiga toxin 2 by an A subunit-specific human monoclonal antibody. Infect. Immun. 76:1931-1939. http://dx.doi.org/10.1128/IAI.01282-07.
45. Smith MJ, Melton-Celsa AR, Sinclair JF, Carvalho HM, Robinson CM, O'Brien AD. 2009. Monoclonal antibody 11E10, which neutralizes Shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin. Infect. Immun. 77:2730-2740. http://dx.doi.org/ 10.1128/IAI.00005-09.
46. Song K, Mize RR, Marrero L, Corti M, Kirk JM, Pincus SH. 2013. Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized. PLoS One 8:e62417. http://dx.doi.org/10.1371/journal.pone.0062417.
47. Bolte S, Cordelières FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224:213-232. http:// dx.doi.org/10.1111/j.1365-2818.2006.01706.x.
48. Neal LM, O'Hara J, Brey RN, Mantis NJ, Brey RN, III, Mantis NJ. 2010. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect. Immun. 78:552-561. http://dx.doi.org/10.1 128/IAI.00796-09.